Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.473, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemfibrozil warranted for primary prevention of CHD
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :
Access to resources
Recommend
Rethink use of statins for primary prevention in CHD?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. :
Raloxifene warranted for fracture prevention in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
HRT solely for prevention of CHD in postmenopausal women
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
Stress testing not worthwhile for targeting CHD prevention
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. :